20140929

Sticking it out

There is a new drug coming out that works similarly to Gilenya: RPC1063. It works by 'modulating the sphingosine-1-phosphate (S1P) receptor, which controls the autoimmune reaction in the lymph nodes'.

Ok, a little above me. All I know is the Tysabri is rocking for me, even on an eight-week dose schedule. I'm going to hold on to that drug as there is a 'rebound effect'...I'm pretty scared of that. So I'm stuck on a kick-butt drug. Could be worse, but hopefully the eight-week schedule will keep the PML away.

No comments:

Post a Comment

SPAM is strictly prohibited and will be removed!